JP2022514734A5 - - Google Patents
Info
- Publication number
- JP2022514734A5 JP2022514734A5 JP2021533155A JP2021533155A JP2022514734A5 JP 2022514734 A5 JP2022514734 A5 JP 2022514734A5 JP 2021533155 A JP2021533155 A JP 2021533155A JP 2021533155 A JP2021533155 A JP 2021533155A JP 2022514734 A5 JP2022514734 A5 JP 2022514734A5
- Authority
- JP
- Japan
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025086417A JP2025128164A (ja) | 2018-12-11 | 2025-05-23 | 抗ｔｒｅｍ２抗体の使用方法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2018/065026 WO2019118513A1 (en) | 2017-12-12 | 2018-12-11 | Anti-trem2 antibodies and related methods |
| USPCT/US2018/065026 | 2018-12-11 | ||
| US201962889990P | 2019-08-21 | 2019-08-21 | |
| US62/889,990 | 2019-08-21 | ||
| PCT/US2019/065743 WO2020123664A1 (en) | 2018-12-11 | 2019-12-11 | Methods of using anti-trem2 antibodies |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025086417A Division JP2025128164A (ja) | 2018-12-11 | 2025-05-23 | 抗ｔｒｅｍ２抗体の使用方法 |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022514734A JP2022514734A (ja) | 2022-02-15 |
| JPWO2020123664A5 JPWO2020123664A5 (https=) | 2022-12-15 |
| JP2022514734A5 true JP2022514734A5 (https=) | 2022-12-15 |
| JP7688579B2 JP7688579B2 (ja) | 2025-06-04 |
Family
ID=71076653
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021533155A Active JP7688579B2 (ja) | 2018-12-11 | 2019-12-11 | 抗ｔｒｅｍ２抗体の使用方法 |
| JP2025086417A Pending JP2025128164A (ja) | 2018-12-11 | 2025-05-23 | 抗ｔｒｅｍ２抗体の使用方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025086417A Pending JP2025128164A (ja) | 2018-12-11 | 2025-05-23 | 抗ｔｒｅｍ２抗体の使用方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20210317211A1 (https=) |
| EP (1) | EP3893931A4 (https=) |
| JP (2) | JP7688579B2 (https=) |
| KR (1) | KR20210104079A (https=) |
| CN (1) | CN113194994B (https=) |
| AU (1) | AU2019397479A1 (https=) |
| CA (1) | CA3120875A1 (https=) |
| WO (1) | WO2020123664A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2961950A1 (en) | 2014-09-28 | 2016-03-31 | The Regents Of The University Of California | Modulation of stimulatory and non-stimulatory myeloid cells |
| WO2019118513A1 (en) | 2017-12-12 | 2019-06-20 | Pionyr Immunotherapeutics, Inc. | Anti-trem2 antibodies and related methods |
| PH12021552002A1 (en) | 2019-02-20 | 2022-09-19 | Denali Therapeutics Inc | Anti-trem2 antibodies and methods of use thereof |
| PE20221465A1 (es) | 2020-01-13 | 2022-09-21 | Denali Therapeutics Inc | Anticuerpos anti-trem2 y metodos para utilizarlos |
| CN113929785B (zh) * | 2021-09-10 | 2023-05-23 | 钦元再生医学(珠海)有限公司 | 一种可自分泌pd1-trem2双特异性抗体的嵌合抗原受体免疫细胞及其应用 |
| WO2024250809A1 (zh) * | 2023-06-08 | 2024-12-12 | 成都优洛生物科技有限公司 | 抗trem2全人源抗体或其抗原结合片段及其应用 |
| US20250101101A1 (en) | 2023-09-01 | 2025-03-27 | iTeos Belgium SA | Anti-trem2 antibodies and methods of use |
| CN119775421B (zh) * | 2023-12-21 | 2025-10-31 | 华润生物医药有限公司 | 抗trem2抗体及其用途 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201311487D0 (en) * | 2013-06-27 | 2013-08-14 | Alligator Bioscience Ab | Bispecific molecules |
| EP3177322A4 (en) | 2014-08-08 | 2018-07-18 | Alector LLC | Anti-trem2 antibodies and methods of use thereof |
| CA2961950A1 (en) | 2014-09-28 | 2016-03-31 | The Regents Of The University Of California | Modulation of stimulatory and non-stimulatory myeloid cells |
| WO2017058866A1 (en) | 2015-09-28 | 2017-04-06 | Precision Immune, Inc. | Anti-trem2 antibodies and uses thereof |
| AU2016334051B2 (en) * | 2015-10-06 | 2023-10-26 | Alector Llc | Anti-TREM2 antibodies and methods of use thereof |
| JP2019516362A (ja) * | 2016-04-27 | 2019-06-20 | ファイザー・インク | 抗ｉｌ−３３抗体、その組成物、方法および使用 |
| WO2019118513A1 (en) * | 2017-12-12 | 2019-06-20 | Pionyr Immunotherapeutics, Inc. | Anti-trem2 antibodies and related methods |
-
2019
- 2019-12-11 WO PCT/US2019/065743 patent/WO2020123664A1/en not_active Ceased
- 2019-12-11 JP JP2021533155A patent/JP7688579B2/ja active Active
- 2019-12-11 CA CA3120875A patent/CA3120875A1/en active Pending
- 2019-12-11 KR KR1020217021577A patent/KR20210104079A/ko not_active Ceased
- 2019-12-11 AU AU2019397479A patent/AU2019397479A1/en active Pending
- 2019-12-11 CN CN201980081883.4A patent/CN113194994B/zh active Active
- 2019-12-11 EP EP19895894.4A patent/EP3893931A4/en not_active Withdrawn
-
2021
- 2021-06-10 US US17/344,839 patent/US20210317211A1/en active Pending
-
2025
- 2025-05-23 JP JP2025086417A patent/JP2025128164A/ja active Pending